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Autism spectrum disorders (ASD) are neurodevelopmental 
disorders, with heterogeneous aetiology, characterized by defi-
ciencies in social interaction and communication and by repeti-
tive and stereotyped behaviours.
The frequent association of ASD with other neurological 
and extra-neurological signs suggests that autism could be con-
sidered as a multiorgan systemic disorder with a primary central 
nervous system involvement.
Evidence  of  mitochondrial  dysfunction  (MD)  and  other 
neuromuscular  disorder  (dystrophinopathies  and  congenital 
muscular dystrophy due to mutations of POMGnT1 gene) has 
been documented in a subset of patients affected by syndromic 
ASD, however, only few case reports and small samples studies 
with specific features have been reported in literature.
During our clinical activity, in order to identify the etio-
pathogenesis of patients with ASD, we selected 12 patients 
(10 males and 2 female) with ASD (2 with autism and 10 with 
ASD NOS) presenting also additional signs suggestive of neu-
romuscular disease. For these patients we carried out muscle 
biopsy for further histological, biochemical and genetic inves-
tigations.
All patients presented MR and muscle hypotonia. Blood 
CK was elevated in 2 patients and lactic acid was increased in 5. 
EMG was myogenic in 5 and neurogenic 5 subjects. EEG find-
ings were abnormal in 8 patients. Brain MRI showed variously 
associated malformative, atrophic changes and white matter al-
terations in 9 patients.
On histological examination of skeletal muscle we found 
myogenic or neurogenic changes in 10 patients, 6 of them pre-
sented also other morphological abnormalities, such as lipid 
accumulation, and/or mitochondrial proliferation, and/or COX 
deficient fibers. At biochemical investigations deficiency of the 
respiratory chain complex I, complex IV, and complex I, II and 
II+III was detected in 3 patients respectively.
Finally, genetic studies revealed multiple deletions of mtD-
NA in 1 patient with normal histological and biochemical find-
ings, the already known homoplasmic C4320T in tRNAIle in 1 
patient and a new nucleotide change A9234G (M10V) of COX 
3 gene in a patient with COX deficient fibers.
Muscle  involvement  was  found  in  almost  all  patients 
(10/12) and mitochondrial dysfunctions in the 50% (6/12) of 
the samples examined. Additional studies in a larger group of 
subjects are needed, in order to confirm the hypothesis of an ae-
tiological link between autism, mitochondrial dysfunction and 
other different neuromuscular diseases.